Singapore: A Chinese research team, led by Anhui Medical University and BGI, has found the strong genetic evidences of m...
Singapore: PRA, a clinical research organization, has opened a second office in China to accommodate its continued expan...
Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning...
Singapore: With the number of H7N9 cases increasing in China, the country has now reported five new cases and one death ...
Singapore: An international research consortium, led by Fujian Agriculture, Forestry University (FAFU) and Beijing Geno...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...
Singapore: Chinese eCommerce giant, Alibaba Group has announced that it would help fund a pharmaceutical information pla...
Bangalore: Following a change in rules for importing active substances into the European Union for medicinal products fo...
Singapore: The HealthTrust Purchasing Group is renewing its agreement for the entire range of physiological patient moni...
Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical com...
Singapore: Sihuan Pharmaceutical's new category 3.1 drug, Nalmefene Hydrochloride Injection (Nalmefene Hydrochloride), ...
Singapore: The Children's Hospital of Philadelphia (CHOP), US, and BGI-Shenzhen, China, announced a formal agreement to...
Life sciences industry in the Asia Pacific recorded the double digit growth of 16.6 percent, reaching $128.26 billion in...
Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...
Singapore: Chinese scientists have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb)....
Singapore: ShangPharma highlighted that its board of directors received a non-binding proposal letter dated July 6, 2012...
